Phyto A+ Brightening Treatment - 30ml
Daily Moisturizer with Azelaic Acid
A smoothing lightweight moisturizer with a gel-cream texture ideal for blemish-prone skin.
Phyto A+ Brightening Treatment is a lightweight moisturizer that helps soothe and correct out-of-balance skin to improve brightness, texture, and clarity. It is suitable for all skin types and our best face moisturizer for oily skin and acne-prone skin. An oil-free moisturizer, it is formulated with 3% azelaic acid, 2% alpha arbutin, and 5.75% phyto botanical blend to target key factors of surface imperfections and dull skin. This non comedogenic moisturizer and skin brightening treatment visibly relieves redness due to dryness and reduces excess oil. The formula smooths skin and minimizes the appearance of pores for enhanced clarity and brighter looking skin.
RECOMMENDED FOR
• Dry
• Normal
• Oily
• Combination
• Sensitive
• Dehydrated
• Sensitized
• Discoloration
• Dull
• Acne
How to Use Phyto A + Brightening
1. Prep + Dispense
Twice a day, after cleansing, dispense 1-2 pumps into clean hands.
2. Apply + Complete
Gently press evenly into skin. Follow with sunscreen.
Phyto A+ Brightening Benefits
- Brightens, while reducing post-blemish marks by 20%
- Smooths, while improving rough skin texture by 19%
- Clarifies, while reducing pore-clogging surface oil by 28%
- Lightweight, non-greasy, gel-cream texture
- Oil- and silicone-free
- Non-comedogenic
- Suitable for sensitive skin
- Clinically effective and studied in all skin tones
Phyto A+ Brightening Treatment- SCIENCE + PROOF
Visible Results
In a 12-week clinical study, Phyto A+ Brightening
Treatment visibly improved skin brightness, smoothness,
and clarity, while reducing pore-clogging surface oil.
Protocol
A 12-week, single-center, clinical study was conducted on 64 female and male subjects, ages 18 to 55, Fitzpatrick I-VI, with normal to oily skin types and mild to moderate skin discoloration and rough texture. Phyto A+ Brightening Treatment was applied to the face twice a day in conjunction with a sunscreen. Evaluations were conducted at baseline and at weeks 2, 4, 8, and 12.
